Forty thousand employees, and a licence metric that counts every one of them. The claim did not survive an inventory that separated Oracle Java from everything else.
How to Negotiate the Oracle Java Employee Agreement: Honest Leverage in a Captive Deal
Priced per employee, every employee, from $15 down to $5.25. At renewal your leverage is thin and OpenJDK threats rarely land. The one-year runway, trading through the wider Oracle relationship, and containing what you sign.
Mercy Health is one of the largest Catholic healthcare networks in the United States, operating across multiple states with roughly forty thousand employees. Oracle opened a Java claim of approximately four million dollars.
The size follows directly from the metric. Oracle's Java SE Universal Subscription is priced per employee, so a forty thousand person network is priced on forty thousand people regardless of how many of them ever touch Java.
The claim closed at zero. Not reduced, not settled at a discount. The evidence did not support a requirement, and once that was demonstrated there was nothing left to price.
Around forty thousand employees across a multi state hospital and clinic network, with a technology estate that is unusually varied even by healthcare standards.
Clinical environments are the hardest place to answer a Java question. Medical device software, imaging systems, laboratory equipment and electronic health record modules all commonly ship their own Java runtime, supplied and controlled by the vendor rather than by the hospital.
Add a large clinical workstation estate and a long tail of departmental applications, and the question is genuinely difficult to answer from memory. It is not difficult to answer from evidence.
Oracle's opening claim totalled approximately four million dollars, priced across the full employee population under the Universal Subscription metric.
Under that metric the arithmetic is straightforward for Oracle. If any Oracle Java requirement exists anywhere in the organization, the subscription is priced for everybody, so the size of the deployment barely affects the number.
That is exactly why the defence cannot be about volume. It has to be about whether the requirement exists at all, and across which software.
The whole engagement rested on one distinction: not all Java is Oracle Java. OpenJDK builds run the same code and carry no Oracle subscription requirement.
We inventoried the estate by distribution rather than by presence of Java, separating Oracle's own binaries from OpenJDK builds and from runtimes embedded inside third party clinical applications.
The embedded category mattered more here than on a typical corporate estate. Where a device or clinical system vendor ships and controls its own runtime, the licensing position sits with that vendor's agreement rather than with the hospital.
We then assembled dated evidence for every Oracle Java removal the organization had already performed, which is the step most estates skip and the one that decides the argument.
These are the moves that closed the claim. The first three carried it.
Mercy Health closed the Oracle Java claim at zero cost, approximately four million dollars below Oracle's opening position.
Audit close versus opening claim
| Position | Claim value |
|---|---|
| Oracle opening Java claim | Approximately $4M |
| Final settlement | $0 |
| Saving against the opening claim | Approximately 100 percent |
The durable outcome is the evidence base. The network now holds an inventory that distinguishes distributions, a documented removal trail, and download controls that stop the exposure quietly rebuilding.
The eleven moves, the employee metric explained, separating Oracle builds from OpenJDK, evidencing removal, and the buyer side position at every step of a Java audit.
Used across more than five hundred enterprise clients. Independent. Buyer side. Built for CIOs running the next Oracle Java audit cycle.
Oracle framed the Oracle Java audit as the immediate Oracle Java uplift at the audit cycle. Redress reframed the approach around Mercy Health's actual Oracle Java deployment. Four million dollars resolved at zero cost.
Twenty years on the buy side. 500+ enterprises. $2B in client savings.
Oracle Java audit signals, Oracle Java SE Universal Subscription signals, Oracle Java OpenJDK alternative signals, and the broader Oracle Java licensing leverage signals across the practice.
